Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
https://www.nature.com/articles/s41379-020-00688-4.pdf
Reference53 articles.
1. Pavlisko EN, Roggli VL. Sarcomatoid peritoneal mesothelioma: clinicopathologic correlation of 13 cases. Am J Surg Pathol. 2015;39:1568–75.
2. Soeberg MJ, Creighton N, Currow DC, Young JM, van Zandwijk N. Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009. Aust N. Z J Public Health. 2016;40:255–62.
3. Butnor KJ, Pavlisko EN, Sporn TA, Roggli VL. Mesothelioma of the tunica vaginalis testis. Hum Pathol. 2019;92:48–58.
4. Le Stang N, Bouvier V, Glehen O, Villeneuve L, Galateau-Salle F, Clin B. Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: a population-based study. Cancer Epidemiol. 2019;60:106–11.
5. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol. 1988;6:147–53.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Histoséminaire biopsies péritonéales tumorales. Cas no 5 et no 6;Annales de Pathologie;2024-07
2. Head‐to‐head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?;Histopathology;2024-05-10
3. Consensus Guideline for the Management of Patients with Peritoneal Mesothelioma;2024-04-13
4. Implementation of a high-resolution, high-contrast magnetic resonance imaging protocol with extended delayed phases for peritoneal mesothelioma;Quantitative Imaging in Medicine and Surgery;2024-03
5. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma;Molecular Cancer;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3